{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/dyspepsia-pregnancy-associated/prescribing-information/ranitidine/","result":{"pageContext":{"chapter":{"id":"60de1b71-33b9-5a85-8db2-22f04ab2568c","slug":"ranitidine","fullItemName":"Ranitidine","depth":2,"htmlHeader":"<!-- begin field bfd4bab2-1398-4eb7-b4c8-d0a5e69afed2 --><h2>Ranitidine</h2><!-- end field bfd4bab2-1398-4eb7-b4c8-d0a5e69afed2 -->","summary":"","htmlStringContent":"<!-- begin item 16389894-a0fc-44b4-93e3-45087ecd18f5 --><!-- end item 16389894-a0fc-44b4-93e3-45087ecd18f5 -->","topic":{"id":"b8d88ee2-8a69-52eb-9d32-912284197e1f","topicId":"dc0be124-58d0-4024-933f-b2fbd474ded2","topicName":"Dyspepsia - pregnancy-associated","slug":"dyspepsia-pregnancy-associated","lastRevised":"Last revised in April 2017","chapters":[{"id":"60f9996f-609e-58ab-a9f8-6c7592ee178e","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"c2b3abe4-1e96-5b8c-b8d3-09d2cb373103","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"a73c5a28-6104-52d9-800f-46667f547593","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"47b7f91b-c83d-54ef-8574-e76eb372bd2f","slug":"changes","fullItemName":"Changes"},{"id":"4f2d76ee-05fa-5ad6-9f05-94ce8aeea75c","slug":"update","fullItemName":"Update"}]},{"id":"e3b58cd1-dacb-5e2b-83a8-3f22adb3d45e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"1f0a7f78-310a-5b31-bfaf-767b6e748abc","slug":"goals","fullItemName":"Goals"},{"id":"9c124ebe-f349-5be6-aceb-708911d511ab","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8fa88023-a3f6-51d6-9cf0-8e6cafd2a378","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8bc89572-4ae3-55e9-a17a-dcdf07479f7e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1b45fcb4-c387-513f-85da-a5f4d0d06c44","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"45c50037-8ca1-55b5-a6aa-9fda720d7647","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ee1aafc3-d046-5f55-8326-4f6eea576ad4","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a33a561f-20e2-5055-93ea-13e7f9792241","slug":"definition","fullItemName":"Definition"},{"id":"c0a56bee-ebd7-515f-ad7a-e659b803ef4f","slug":"causes","fullItemName":"Causes"},{"id":"43050203-854e-501c-969a-4ef9ca2e693a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"d37ff081-b4e8-5bed-8525-97babc845cc3","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"1e7d1d6b-e749-549b-80e1-505aeae8c3b0","slug":"complications","fullItemName":"Complications"},{"id":"e925ce1f-978f-5f2d-95c4-42e4c5329ba9","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"5b93254f-d6b2-548f-8332-981acee23d8d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"37e18679-14e0-55e8-9ff3-98ec1f8b4dc8","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"9df83943-7b99-5528-b96d-cf1a3d31e340","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"4d3fcf99-02c1-5ae0-a88f-6ede4299e2e4","fullItemName":"Management","slug":"management","subChapters":[{"id":"7d3d9638-da7b-5e7c-bee8-d2cddbe706f0","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"b7e38fc5-888d-5f8f-b554-d5a6d7c0169e","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"891c5a5d-fe64-5740-8bea-1288bb40fe1d","slug":"antacids-alginates","fullItemName":"Antacids and alginates"},{"id":"60de1b71-33b9-5a85-8db2-22f04ab2568c","slug":"ranitidine","fullItemName":"Ranitidine"},{"id":"a4e035b2-17fe-5771-bf7c-e6316042dfea","slug":"omeprazole","fullItemName":"Omeprazole"}]},{"id":"dd43a335-6bef-54d0-b721-23c0399cbca6","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"1b228dcd-0e8b-5fbb-8dd4-a3307cb52b3d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"436e8102-5b89-580c-8c58-6895cda4ae97","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"178fa7df-fb25-5bda-bd69-1cebda0cbbf0","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"09c54592-0d38-52dc-b0b8-33b5dea6130e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ad6eb72f-398b-5f96-bd8d-c07cdd9bd570","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"56db1aa0-6292-5b08-9b08-7addf535756d","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f687e796-c2d6-5737-86fe-8977f4ba5257","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b7e38fc5-888d-5f8f-b554-d5a6d7c0169e","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"74911552-83b8-5d88-8e04-f6fdca2f0aa5","slug":"dosage","fullItemName":"Dosage","depth":3,"htmlHeader":"<!-- begin field 650cdab8-0ad7-4420-86f1-a73500a05e8e --><h3>What dosage of ranitidine should I prescribe?</h3><!-- end field 650cdab8-0ad7-4420-86f1-a73500a05e8e -->","summary":"","htmlStringContent":"<!-- begin item 6315ffd1-b13a-43d7-95ae-a73500a05c17 --><!-- begin field 6ce9f483-70b9-4793-865e-a73500a05e8e --><ul><li>The use of ranitidine is off-label in pregnancy.</li><li>CKS recommends the usual dosage for gastro-oesophageal reflux disease; 150 mg, twice a day [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-pregnancy-associated/references/\">BNF 72, 2016</a>].<ul><li>This is consistent with a randomized control trial which found a lower dosage (150 mg, once a day) to be ineffective [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-pregnancy-associated/references/\">Larson et al, 1997</a>]. </li></ul></li></ul><!-- end field 6ce9f483-70b9-4793-865e-a73500a05e8e --><!-- end item 6315ffd1-b13a-43d7-95ae-a73500a05c17 -->","subChapters":[]},{"id":"306b36ff-0200-56b0-ae2d-e2e601c9004e","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 61d62ce6-fb87-45b9-aa1f-a73500a08570 --><h3>What contraindications and cautions are associated with ranitidine?</h3><!-- end field 61d62ce6-fb87-45b9-aa1f-a73500a08570 -->","summary":"","htmlStringContent":"<!-- begin item 8209754b-bf35-4a19-8f08-a73500a08362 --><!-- begin field 1eadf485-d746-409a-ac11-a73500a08570 --><ul><li>Do not prescribe ranitidine if the person has a history of:<ul><li>Hypersensitivity to the drug or its excipients.</li><li>Features suggesting malignancy — exclude malignancy before prescribing, as ranitidine can mask the symptoms of gastric cancer.</li><li>Porphyria — ranitidine may precipitate acute porphyric attacks.</li></ul></li><li>Prescribe ranitidine with caution if the person:<ul><li>Has renal impairment — if the person's estimated glomerular filtration rate (eGFR) is less than 50 mL/minute/1.73m<sup>2</sup>, use half the normal dose. </li><li>Is immunocompromised, or has diabetes or chronic lung disease — the risk of developing community-acquired pneumonia may be increased.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-pregnancy-associated/references/\">ABPI Medicines Compendium, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-pregnancy-associated/references/\">BNF 72, 2016</a>]</p><!-- end field 1eadf485-d746-409a-ac11-a73500a08570 --><!-- end item 8209754b-bf35-4a19-8f08-a73500a08362 -->","subChapters":[]},{"id":"785a80af-fece-5991-b563-edcd7282f20e","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 4f4fb61c-ead2-44d9-8884-a73500a0a9a4 --><h3>What adverse effects are associated with ranitidine?</h3><!-- end field 4f4fb61c-ead2-44d9-8884-a73500a0a9a4 -->","summary":"","htmlStringContent":"<!-- begin item 1b9d1866-c9b8-499a-96f9-a73500a0a7a2 --><!-- begin field 82267e42-d84d-4704-911d-a73500a0a9a4 --><ul><li>Adverse effects reported with the H<sub>2</sub>-receptor antagonists include diarrhoea, headache, and dizziness.</li><li>Less common adverse effects include:<ul><li>Rash.</li><li>Abdominal pain, nausea, constipation.</li><li>Hepatitis, cholestatic jaundice.</li><li>Confusion, depression, hallucinations (more likely to occur if the person is severely ill or has renal disease).</li><li>Arthralgia and myalgia.</li><li>Bradycardia, tachycardia, atrio-ventricular block.</li><li>Leucopenia, thrombocytopenia, pancytopenia.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-pregnancy-associated/references/\">ABPI Medicines Compendium, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-pregnancy-associated/references/\">BNF 72, 2016</a>]</p><!-- end field 82267e42-d84d-4704-911d-a73500a0a9a4 --><!-- end item 1b9d1866-c9b8-499a-96f9-a73500a0a7a2 -->","subChapters":[]},{"id":"c0143292-bf1c-5db0-ba3c-d740c787bd72","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field d62ecd7a-2070-4717-9180-a73500a0bea0 --><h3>What are the drug interactions with ranitidine?</h3><!-- end field d62ecd7a-2070-4717-9180-a73500a0bea0 -->","summary":"","htmlStringContent":"<!-- begin item 020c1547-da2d-414a-a883-a73500a0bd20 --><!-- begin field 9f5c204f-418c-4f0c-b87c-a73500a0bea0 --><ul><li>Ranitidine has rarely been reported to alter the prothrombin time in people taking coumarin anticoagulants such as warfarin — monitor prothrombin time during concurrent treatment with ranitidine and warfarin.</li><li>The alteration in gastric pH may affect the absorption of other drugs:<ul><li>Increased absorption, for example glipizide, midazolam.</li><li>Decreased absorption, for example itraconazole, ketoconazole, atazanavir, fosamprenavir.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-pregnancy-associated/references/\">ABPI Medicines Compendium, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-pregnancy-associated/references/\">BNF 72, 2016</a>]</p><!-- end field 9f5c204f-418c-4f0c-b87c-a73500a0bea0 --><!-- end item 020c1547-da2d-414a-a883-a73500a0bd20 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}